nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlormerodrin—Venous thrombosis—Carboplatin—ovarian cancer	0.0632	0.0911	CcSEcCtD
Chlormerodrin—Fluid overload—Carboplatin—ovarian cancer	0.0548	0.079	CcSEcCtD
Chlormerodrin—ALDH5A1—Vinblastine—Vinorelbine—ovarian cancer	0.0416	1	CbGdCrCtD
Chlormerodrin—Extravasation—Carboplatin—ovarian cancer	0.0391	0.0563	CcSEcCtD
Chlormerodrin—ALDH5A1—uterine cervix—ovarian cancer	0.0337	0.127	CbGeAlD
Chlormerodrin—ALDH5A1—decidua—ovarian cancer	0.0321	0.121	CbGeAlD
Chlormerodrin—Phlebitis—Carboplatin—ovarian cancer	0.0287	0.0414	CcSEcCtD
Chlormerodrin—ALDH5A1—gonad—ovarian cancer	0.0283	0.107	CbGeAlD
Chlormerodrin—SLC12A1—epithelium—ovarian cancer	0.0254	0.0957	CbGeAlD
Chlormerodrin—ALDH5A1—female reproductive system—ovarian cancer	0.0253	0.0954	CbGeAlD
Chlormerodrin—ALDH5A1—bone marrow—ovarian cancer	0.0238	0.0901	CbGeAlD
Chlormerodrin—ALDH5A1—female gonad—ovarian cancer	0.023	0.0868	CbGeAlD
Chlormerodrin—ALDH5A1—vagina—ovarian cancer	0.0228	0.0863	CbGeAlD
Chlormerodrin—ALDH5A1—testis—ovarian cancer	0.0204	0.077	CbGeAlD
Chlormerodrin—Extravasation—Topotecan—ovarian cancer	0.0179	0.0258	CcSEcCtD
Chlormerodrin—Extravasation—Melphalan—ovarian cancer	0.0175	0.0253	CcSEcCtD
Chlormerodrin—Necrosis—Vinorelbine—ovarian cancer	0.017	0.0245	CcSEcCtD
Chlormerodrin—Venous thrombosis—Paclitaxel—ovarian cancer	0.0166	0.024	CcSEcCtD
Chlormerodrin—Ulcer—Melphalan—ovarian cancer	0.0162	0.0233	CcSEcCtD
Chlormerodrin—Extravasation—Vinorelbine—ovarian cancer	0.0153	0.0221	CcSEcCtD
Chlormerodrin—SLC12A1—testis—ovarian cancer	0.0152	0.0574	CbGeAlD
Chlormerodrin—ALDH5A1—lymph node—ovarian cancer	0.0148	0.0558	CbGeAlD
Chlormerodrin—Infection—Carboplatin—ovarian cancer	0.0121	0.0174	CcSEcCtD
Chlormerodrin—Necrosis—Paclitaxel—ovarian cancer	0.0114	0.0165	CcSEcCtD
Chlormerodrin—Phlebitis—Vinorelbine—ovarian cancer	0.0113	0.0162	CcSEcCtD
Chlormerodrin—Vomiting—Altretamine—ovarian cancer	0.0112	0.0161	CcSEcCtD
Chlormerodrin—Hyponatraemia—Melphalan—ovarian cancer	0.0111	0.0161	CcSEcCtD
Chlormerodrin—Nausea—Altretamine—ovarian cancer	0.0105	0.0151	CcSEcCtD
Chlormerodrin—Tenderness—Paclitaxel—ovarian cancer	0.0103	0.0148	CcSEcCtD
Chlormerodrin—Extravasation—Paclitaxel—ovarian cancer	0.0103	0.0148	CcSEcCtD
Chlormerodrin—Hyponatraemia—Vinorelbine—ovarian cancer	0.00973	0.014	CcSEcCtD
Chlormerodrin—Necrosis—Docetaxel—ovarian cancer	0.0097	0.014	CcSEcCtD
Chlormerodrin—Body temperature increased—Carboplatin—ovarian cancer	0.00961	0.0139	CcSEcCtD
Chlormerodrin—Venous thrombosis—Epirubicin—ovarian cancer	0.00951	0.0137	CcSEcCtD
Chlormerodrin—Venous thrombosis—Doxorubicin—ovarian cancer	0.0088	0.0127	CcSEcCtD
Chlormerodrin—Extravasation—Docetaxel—ovarian cancer	0.00873	0.0126	CcSEcCtD
Chlormerodrin—Phlebitis—Paclitaxel—ovarian cancer	0.00757	0.0109	CcSEcCtD
Chlormerodrin—Hyponatraemia—Paclitaxel—ovarian cancer	0.00655	0.00944	CcSEcCtD
Chlormerodrin—Necrosis—Epirubicin—ovarian cancer	0.00654	0.00943	CcSEcCtD
Chlormerodrin—Abscess—Epirubicin—ovarian cancer	0.00649	0.00936	CcSEcCtD
Chlormerodrin—Phlebitis—Docetaxel—ovarian cancer	0.00641	0.00925	CcSEcCtD
Chlormerodrin—Infection—Chlorambucil—ovarian cancer	0.00622	0.00896	CcSEcCtD
Chlormerodrin—Necrosis—Doxorubicin—ovarian cancer	0.00605	0.00873	CcSEcCtD
Chlormerodrin—Abscess—Doxorubicin—ovarian cancer	0.006	0.00866	CcSEcCtD
Chlormerodrin—Extravasation—Epirubicin—ovarian cancer	0.00589	0.00849	CcSEcCtD
Chlormerodrin—Hyponatraemia—Docetaxel—ovarian cancer	0.00555	0.008	CcSEcCtD
Chlormerodrin—Infection—Topotecan—ovarian cancer	0.00553	0.00798	CcSEcCtD
Chlormerodrin—Gastrointestinal haemorrhage—Docetaxel—ovarian cancer	0.00553	0.00797	CcSEcCtD
Chlormerodrin—Extravasation—Doxorubicin—ovarian cancer	0.00545	0.00785	CcSEcCtD
Chlormerodrin—Ulcer—Epirubicin—ovarian cancer	0.00543	0.00783	CcSEcCtD
Chlormerodrin—Infection—Melphalan—ovarian cancer	0.00542	0.00781	CcSEcCtD
Chlormerodrin—Hyperkalaemia—Epirubicin—ovarian cancer	0.00504	0.00727	CcSEcCtD
Chlormerodrin—Ulcer—Doxorubicin—ovarian cancer	0.00502	0.00724	CcSEcCtD
Chlormerodrin—Body temperature increased—Chlorambucil—ovarian cancer	0.00495	0.00713	CcSEcCtD
Chlormerodrin—Infection—Vinorelbine—ovarian cancer	0.00473	0.00682	CcSEcCtD
Chlormerodrin—Hyperkalaemia—Doxorubicin—ovarian cancer	0.00467	0.00673	CcSEcCtD
Chlormerodrin—Body temperature increased—Topotecan—ovarian cancer	0.0044	0.00635	CcSEcCtD
Chlormerodrin—Phlebitis—Epirubicin—ovarian cancer	0.00433	0.00624	CcSEcCtD
Chlormerodrin—Diarrhoea—Chlorambucil—ovarian cancer	0.00428	0.00617	CcSEcCtD
Chlormerodrin—Phlebitis—Doxorubicin—ovarian cancer	0.004	0.00577	CcSEcCtD
Chlormerodrin—Vomiting—Chlorambucil—ovarian cancer	0.00398	0.00574	CcSEcCtD
Chlormerodrin—Flatulence—Paclitaxel—ovarian cancer	0.00387	0.00558	CcSEcCtD
Chlormerodrin—Diarrhoea—Topotecan—ovarian cancer	0.00381	0.00549	CcSEcCtD
Chlormerodrin—Body temperature increased—Vinorelbine—ovarian cancer	0.00377	0.00543	CcSEcCtD
Chlormerodrin—Hyponatraemia—Epirubicin—ovarian cancer	0.00374	0.0054	CcSEcCtD
Chlormerodrin—Diarrhoea—Melphalan—ovarian cancer	0.00373	0.00538	CcSEcCtD
Chlormerodrin—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.00373	0.00537	CcSEcCtD
Chlormerodrin—Nausea—Chlorambucil—ovarian cancer	0.00372	0.00536	CcSEcCtD
Chlormerodrin—Vomiting—Topotecan—ovarian cancer	0.00354	0.00511	CcSEcCtD
Chlormerodrin—Rash—Topotecan—ovarian cancer	0.00351	0.00506	CcSEcCtD
Chlormerodrin—Dermatitis—Topotecan—ovarian cancer	0.00351	0.00506	CcSEcCtD
Chlormerodrin—Vomiting—Melphalan—ovarian cancer	0.00347	0.005	CcSEcCtD
Chlormerodrin—Hyponatraemia—Doxorubicin—ovarian cancer	0.00346	0.00499	CcSEcCtD
Chlormerodrin—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.00345	0.00497	CcSEcCtD
Chlormerodrin—Rash—Melphalan—ovarian cancer	0.00344	0.00496	CcSEcCtD
Chlormerodrin—Dermatitis—Melphalan—ovarian cancer	0.00344	0.00495	CcSEcCtD
Chlormerodrin—Nausea—Topotecan—ovarian cancer	0.00331	0.00477	CcSEcCtD
Chlormerodrin—Diarrhoea—Vinorelbine—ovarian cancer	0.00326	0.0047	CcSEcCtD
Chlormerodrin—Nausea—Melphalan—ovarian cancer	0.00324	0.00467	CcSEcCtD
Chlormerodrin—Infection—Paclitaxel—ovarian cancer	0.00318	0.00459	CcSEcCtD
Chlormerodrin—Vomiting—Vinorelbine—ovarian cancer	0.00303	0.00437	CcSEcCtD
Chlormerodrin—Rash—Vinorelbine—ovarian cancer	0.003	0.00433	CcSEcCtD
Chlormerodrin—Dermatitis—Vinorelbine—ovarian cancer	0.003	0.00433	CcSEcCtD
Chlormerodrin—Nausea—Vinorelbine—ovarian cancer	0.00283	0.00408	CcSEcCtD
Chlormerodrin—Infection—Docetaxel—ovarian cancer	0.0027	0.00389	CcSEcCtD
Chlormerodrin—Body temperature increased—Paclitaxel—ovarian cancer	0.00253	0.00365	CcSEcCtD
Chlormerodrin—Flatulence—Epirubicin—ovarian cancer	0.00221	0.00319	CcSEcCtD
Chlormerodrin—Diarrhoea—Paclitaxel—ovarian cancer	0.00219	0.00316	CcSEcCtD
Chlormerodrin—Body temperature increased—Docetaxel—ovarian cancer	0.00215	0.0031	CcSEcCtD
Chlormerodrin—Flatulence—Doxorubicin—ovarian cancer	0.00205	0.00295	CcSEcCtD
Chlormerodrin—Vomiting—Paclitaxel—ovarian cancer	0.00204	0.00294	CcSEcCtD
Chlormerodrin—Rash—Paclitaxel—ovarian cancer	0.00202	0.00291	CcSEcCtD
Chlormerodrin—Dermatitis—Paclitaxel—ovarian cancer	0.00202	0.00291	CcSEcCtD
Chlormerodrin—Nausea—Paclitaxel—ovarian cancer	0.0019	0.00274	CcSEcCtD
Chlormerodrin—Diarrhoea—Docetaxel—ovarian cancer	0.00186	0.00268	CcSEcCtD
Chlormerodrin—Infection—Epirubicin—ovarian cancer	0.00182	0.00262	CcSEcCtD
Chlormerodrin—Vomiting—Docetaxel—ovarian cancer	0.00173	0.00249	CcSEcCtD
Chlormerodrin—Rash—Docetaxel—ovarian cancer	0.00171	0.00247	CcSEcCtD
Chlormerodrin—Dermatitis—Docetaxel—ovarian cancer	0.00171	0.00247	CcSEcCtD
Chlormerodrin—Infection—Doxorubicin—ovarian cancer	0.00168	0.00243	CcSEcCtD
Chlormerodrin—Nausea—Docetaxel—ovarian cancer	0.00161	0.00233	CcSEcCtD
Chlormerodrin—Body temperature increased—Epirubicin—ovarian cancer	0.00145	0.00209	CcSEcCtD
Chlormerodrin—Body temperature increased—Doxorubicin—ovarian cancer	0.00134	0.00193	CcSEcCtD
Chlormerodrin—Diarrhoea—Epirubicin—ovarian cancer	0.00125	0.00181	CcSEcCtD
Chlormerodrin—Vomiting—Epirubicin—ovarian cancer	0.00116	0.00168	CcSEcCtD
Chlormerodrin—Diarrhoea—Doxorubicin—ovarian cancer	0.00116	0.00167	CcSEcCtD
Chlormerodrin—Rash—Epirubicin—ovarian cancer	0.00116	0.00167	CcSEcCtD
Chlormerodrin—Dermatitis—Epirubicin—ovarian cancer	0.00115	0.00166	CcSEcCtD
Chlormerodrin—Nausea—Epirubicin—ovarian cancer	0.00109	0.00157	CcSEcCtD
Chlormerodrin—Vomiting—Doxorubicin—ovarian cancer	0.00108	0.00155	CcSEcCtD
Chlormerodrin—Rash—Doxorubicin—ovarian cancer	0.00107	0.00154	CcSEcCtD
Chlormerodrin—Dermatitis—Doxorubicin—ovarian cancer	0.00107	0.00154	CcSEcCtD
Chlormerodrin—Nausea—Doxorubicin—ovarian cancer	0.00101	0.00145	CcSEcCtD
